Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > CEO Robert

<< Previous

Bullboard Posts

Next >>

Comment by Captainblkon Dec 30, 2020 1:56pm

202 Views

Post# 32198523

RE:RE:RE:CEO Robert

Chritters wrote:

Captainblk

thats why you dont give any credence to anything outside of official PR.

hell for all we know this "new website" that was mentioned was that shite kalytaran site that looks like it was made during the dot com crash[/quote wrote:

I still think The Kalytaran Website is Robert Fairfull under cover trying to suck people in to buying more and more Shares.

same haha I beleive he's on this board as well

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"